ZayaAI Integrates Paige’s Advanced AI Applications into Its Laboratory Information System (LIS)

Bucharest, Romania – May 12, 2025 – ZayaAI, a leading provider of AI-driven digital pathology solutions, is proud to announce the integration of Paige’s state-of-the-art AI-assisted diagnostic models into its Laboratory Information System (LIS). This strategic collaboration aims to enhance diagnostic efficiency and streamline pathology workflows across various cancer types.

Paige’s AI applications, including Prostate, Breast and GI Suites and PanCancer Detect, are renowned for their ability to assist pathologists in identifying regions of tissue suspicious for cancer. Built on over 3 million pathology slides from more than 800 labs across 45 countries, these applications offer unparalleled insights into cancer detection and characterization.

“Integrating Paige’s AI capabilities into our LIS represents a significant advancement in our mission to provide comprehensive digital pathology solutions,” said Cristian Mogodici, CEO of ZayaAI. “This collaboration empowers pathologists with cutting-edge tools to improve diagnostic confidence and patient outcomes.”

Gerard Slootweg, VP of Sales at Paige, commented, “We’re excited to partner with ZayaAI to bring our AI solutions directly into the pathology workflow. This integration exemplifies our commitment to enhancing diagnostic precision and efficiency through seamless technology adoption.”
The combined expertise of ZayaAI and Paige ensures that healthcare providers have access to a robust, AI-enhanced LIS, facilitating faster and more confident diagnoses.

For more information about ZayaAI‘s integrated solutions, please visit www.zaya.ai.

——

View Press Release 

Next
Next

Paige and NHS Wales Launch PanCancer Pilot to Triage Cases with AI at Betsi Cadwaladr University Health Board